Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geovax Labs (NQ: GOVX )

0.5177 +0.0116 (+2.29%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 126,456
Open 0.5100
Bid (Size) 0.5001 (5)
Ask (Size) 0.5035 (7)
Prev. Close 0.5061
Today's Range 0.5072 - 0.5198
52wk Range 0.5055 - 1.390
Shares Outstanding 26,443,649
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
GeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19

Performance

YTD
-17.60%
-17.60%
1 Month
-16.28%
-16.28%
3 Month
-12.98%
-12.98%
6 Month
-24.97%
-24.97%
1 Year
-48.06%
-48.06%

More News

Read More
GeoVax Presents Corporate Update at the H.C. Wainwright 25th Annual Global Investment Conference
Via NewMediaWire
GeoVax Completes Enrollment of Phase 2 Trial for Next-Generation COVID-19 Vaccine Booster
Via NewMediaWire
Exposures COVID-19 Product Safety
GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update
Via NewMediaWire
GeoVax to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Via NewMediaWire
GeoVax to Present at the Emerging Growth Conference on September 6, 2023
Via NewMediaWire
Exposures COVID-19
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
GeoVax Receives Notice of Allowance for Malaria Vaccine Patent
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
ADDvantage Technologies Group And 3 Other Stocks Under $1 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
GeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
Via NewMediaWire
Exposures COVID-19
GeoVax to Report Second Quarter 2023 Financial Results and Provide Corporate Update on Wednesday, August 9, 2023
Via NewMediaWire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
GeoVax Announces Issuance of Ebola Vaccine Patent
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
GeoVax Announces Initiation of Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia
Via NewMediaWire
Exposures COVID-19
GeoVax Presents Gedeptin(R) Clinical Data at the AACR-AHNS Head and Neck Cancer Conference
Via NewMediaWire
GeoVax Announces Gedeptin(R) Presentation at the AACR-AHNS Head and Neck Cancer Conference
Via NewMediaWire
GeoVax Universal Coronavirus Vaccine Design & Development Approach Published in Vaccine Insights
Via NewMediaWire
Exposures COVID-19
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Sientra Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving Premarket
Via Benzinga
GeoVax Partners With ABL to Advance cGMP Production of Vaccine Candidates
Via NewMediaWire
GeoVax to Participate in Upcoming Industry Meetings
Via NewMediaWire
GeoVax's Next-Gen Single Dose COVID-19 Vaccine Shows Promising Results
Via Benzinga
GeoVaxs Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patients
Via NewMediaWire
Exposures COVID-19
GeoVax Next-Generation COVID-19 Vaccine Data to be Presented at Two Upcoming Scientific Meetings
Via NewMediaWire
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.